AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hormone therapy technology licensed From Wake Forest.(BioSante Pharmaceuticals Inc. signs licensing agreement for triple hormone therapy technology)
2003 JAN 9 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced it has licensed three patents encompassing new combinations of hormone therapies, known as triple hormone therapy, by any route of administration, from Wake Forest University School of Medicine.
Also included in the license is an option to use triple hormones in contraceptives.
The Wake Forest patents cover novel combinations of estrogens and progestins with androgens, such as testosterone, which may have beneficial effects in women. Currently, estrogen plus progestin is indicated for the treatment of menopausal symptoms, including hot flashes and vaginal atrophy, for women with an intact uterus. Testosterone is thought to further alleviate symptoms of menopause and female sexual dysfunction in postmenopausal women.
"This license agreement with Wake Forest for new combination hormone therapies is a very valuable addition to BioSante's hormone therapy product pipeline in development," said Stephen M. Simes, president and chief executive officer of BioSante. "Our products are topical gel formulations for men and women. These gels provide continuous systemic levels of the hormones, which may result in less potential for side effects. With more attention being focused on the safety and efficacy of hormone therapy products, especially among women and their healthcare providers, we believe BioSante's portfolio of hormone therapy gel products positions us well to gain acceptance and market share in the treatment of menopausal symptoms, among other indications."
BioSante currently is testing Bio-T-Gel (gel formulations of testosterone for men), Bio-E-Gel (estradiol for women), and LibiGel (testosterone for treatment of ...
- BioSante Pharmaceuticals Licenses Hormone Therapy Technology From Wake Forest...
- Press release article from: PR Newswire December 5, 2002 700+ words
...known as triple hormone therapy, by any route...administration from Wake Forest University School...agreement with Wake Forest for new combination...to BioSante's hormone therapy product pipeline...Management for Wake Forest, said, "BioSante...technology ...
- Hormone therapy technology licensed From Wake Forest.
- Newspaper article from: Drug Week January 10, 2003 700+ words
...known as triple hormone therapy, by any route...administration, from Wake Forest University School...agreement with Wake Forest for new combination...to BioSante's hormone therapy product pipeline...management for Wake Forest, said, "BioSante...technology ...
- Hormone therapy linked to brain shrinkage, but not lesions.(Clinical report)
- Magazine article from: Women's Health Weekly January 29, 2009 700+ words
...postmenopausal hormone therapy may slightly accelerate...aging (see also Wake Forest University Baptist...Ph.D., of Wake Forest University Baptist...hypothesis that hormone therapy was linked to...women who took hormone therapy closer to the...Women's ...
- Hormone therapy offers no benefit on central nervous system outcomes.
- Magazine article from: Contraceptive Technology Update August 1, 2003 700+ words
...from patients about hormone therapy (HT) with the publication...examine the impact of hormone therapy on central nervous...Salem, NC-based Wake Forest University, who served...examine the effects of hormone therapy termination on cognition...
- Timing of hormone therapy key to success?
- News wire article from: United Press International March 3, 2003 700+ words
...on monkeys at Wake Forest. They also...Starting on hormone therapy that late in...do not begin hormone therapy until age 57...need to take hormone therapy to reap the...results from Wake Forest are interesting...
- Study: Hormone therapy may increase risk of dementia.
- Newspaper article from: The Orlando Sentinel (Orlando, Fla.) (via Knight-Ridder/Tribune News Service) May 27, 2003 700+ words
...taking some form of hormone therapy this time last year...widely used form of hormone therapy: down from about...Prempro. Researchers at Wake Forest found that 61 of those...should not be going on hormone therapy strictly as a way...
- Longer Use of Hormones Fails to Prevent Heart Attacks in Postmenopausal Women...
- News wire article from: Ascribe Higher Education News Service July 2, 2002 700+ words
...attack increased in the hormone therapy group during the first year...effects of longer-duration hormone therapy. The trend toward a reduced...menopause, a few years of hormone therapy will relieve symptoms with...Herrington, MD, MHS, Wake Forest University; Vera ...
- Hormone therapy: issues of the heart. (estrogen replacement therapy and heart...
- Magazine article from: Science News Raloff, Janet March 8, 1997 700+ words
...postmenopausal women. Hormone therapy delivers estrogen...that had received no hormone therapy. Monkeys that had...Koudy Williams of Wake Forest University's Bowman...progesterone was part of the hormone therapy. "There appeared...
Source: HighBeam Research, Hormone therapy technology licensed From Wake Forest.(BioSante...